MA29428B1 - Compositions argent/eau, compositions de gels d'argent, compositions a base d'argent, et leurs methodes de production et d'utilisation - Google Patents

Compositions argent/eau, compositions de gels d'argent, compositions a base d'argent, et leurs methodes de production et d'utilisation

Info

Publication number
MA29428B1
MA29428B1 MA30111A MA30111A MA29428B1 MA 29428 B1 MA29428 B1 MA 29428B1 MA 30111 A MA30111 A MA 30111A MA 30111 A MA30111 A MA 30111A MA 29428 B1 MA29428 B1 MA 29428B1
Authority
MA
Morocco
Prior art keywords
silver
compositions
metal
methods
composition
Prior art date
Application number
MA30111A
Other languages
English (en)
Inventor
Robert Holladay
William Moeller
Dilip Mehta
Juliana H J Brooks
Rustum Roy
Mark Mortenson
Original Assignee
Robert Holladay
William Moeller
Dilip Mehta
Juliana H J Brooks
Rustum Roy
Mark Mortenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36648082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29428(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Robert Holladay, William Moeller, Dilip Mehta, Juliana H J Brooks, Rustum Roy, Mark Mortenson filed Critical Robert Holladay
Publication of MA29428B1 publication Critical patent/MA29428B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'INVENTION CONCERNE UNE COMPOSITION INCOLORE CONSTITUÉE DE PARTICULES MÉTALLIQUES (P. EX. DES NANOPARTICULES D'ARGENT) ET D'EAU, LESDITES PARTICULES COMPRENANT UN NOYAU D'UN MÉTAL ÉLÉMENTAIRE (P. EX. ARGENT) ET UNE ENVELOPPE D'UN OXYDE MÉTALLIQUE (P. EX. UN OU PLUSIEURS OXYDE(S) D'ARGENT). LES NANOPARTICULES MÉTALLIQUES SONT PRÉSENTES DANS L'EAU SELON UNE TENEUR DE 5-40 MG/L, ET LA COMPOSITION MANIFESTE DES PROPRIÉTÉS ANTIMICROBIENNES CONSÉQUENTES. L'INVENTION CONCERNE DES MÉTHODES D'UTILISATION DE LA COMPOSITION. LA COMPOSITION DE L'INVENTION PEUT ÊTRE INCORPORÉE DANS UN HYDROGEL SANS QUASIMENT AUCUNE DÉGRADATION DES PROPRIÉTÉS ANTIMICROBIENNES. L'INVENTION CONCERNE EN OUTRE DIVERSES COMPOSITIONS CONTENANT DU MÉTAL, QUI PRÉSENTENT UNE EFFICACITÉ BIOLOGIQUE INATTENDUE.
MA30111A 2005-01-05 2007-07-26 Compositions argent/eau, compositions de gels d'argent, compositions a base d'argent, et leurs methodes de production et d'utilisation MA29428B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64152105P 2005-01-05 2005-01-05
US69707905P 2005-07-07 2005-07-07
US70249405P 2005-07-26 2005-07-26

Publications (1)

Publication Number Publication Date
MA29428B1 true MA29428B1 (fr) 2008-05-02

Family

ID=36648082

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30111A MA29428B1 (fr) 2005-01-05 2007-07-26 Compositions argent/eau, compositions de gels d'argent, compositions a base d'argent, et leurs methodes de production et d'utilisation

Country Status (14)

Country Link
US (1) US20110262556A1 (fr)
EP (1) EP1880213A4 (fr)
CN (1) CN101389221B (fr)
AU (1) AU2005322839B2 (fr)
BR (1) BRPI0519604A2 (fr)
CA (1) CA2624274A1 (fr)
GE (1) GEP20125593B (fr)
IL (1) IL184455A (fr)
MA (1) MA29428B1 (fr)
MX (1) MX2007008305A (fr)
NZ (1) NZ590025A (fr)
TN (1) TNSN07257A1 (fr)
WO (1) WO2006074117A2 (fr)
ZA (1) ZA200706496B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12257329B2 (en) * 2022-05-12 2025-03-25 Helix Science LLC Composition for the control of oral malodor compounds

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8753691B2 (en) * 1999-06-01 2014-06-17 American Silver, Llc Antiviral colloidal silver composition
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20100272769A1 (en) * 2005-08-03 2010-10-28 Amcol International Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
GB0603487D0 (en) * 2006-02-22 2006-04-05 Agt Sciences Ltd Delivery means
US8361505B1 (en) * 2006-06-28 2013-01-29 Perry Stephen C Method and apparatus for producing a stable sub-colloidal nano-phase silver metal hydrosol
GB0712287D0 (en) 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
US20080103459A1 (en) * 2006-10-30 2008-05-01 Anthony Di Salvo Enzyme inhibition using nanoparticles
KR100912267B1 (ko) 2007-12-05 2009-08-17 윤의식 기능성 농산물의 재배 방법
JP4764452B2 (ja) * 2008-05-23 2011-09-07 宣政 奥田 創傷被覆材及び絆創膏並びにそれらの製造方法
US8178120B2 (en) * 2008-06-20 2012-05-15 Baxter International Inc. Methods for processing substrates having an antimicrobial coating
US8753561B2 (en) 2008-06-20 2014-06-17 Baxter International Inc. Methods for processing substrates comprising metallic nanoparticles
US8277826B2 (en) 2008-06-25 2012-10-02 Baxter International Inc. Methods for making antimicrobial resins
US8540942B2 (en) 2009-01-14 2013-09-24 David Kyle Pierce Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) therefrom
US9387452B2 (en) 2009-01-14 2016-07-12 Gr Intellectual Reserve, Llc. Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
KR101712682B1 (ko) 2009-01-15 2017-03-07 클레네 나노메디슨, 인크. 액체를 처리하고 액체 내의 특정 성분(예를 들어, 나노입자)을 제조하기 위한 연속적, 반연속적 및 일괄식 방법, 장치 및 그로부터 생성된 나노입자 및 나노입자/액체 용액(들) 및 콜로이드
GB0903394D0 (en) * 2009-02-27 2009-04-08 Sentinel Performance Solutions Heat pumps
SG10202108051XA (en) 2009-07-08 2021-09-29 Clene Nanomedicine Inc Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
US10391124B2 (en) * 2009-07-21 2019-08-27 Aidance Skincare & Topical Solutions Llc Silver oxide formulations
WO2011044916A1 (fr) * 2009-10-14 2011-04-21 El Sayed Kamel Morsy Elbaialy Composition désinfectante écologique multi-usage comprenant un agent antibactérien nanométrique
WO2011097546A2 (fr) * 2010-02-06 2011-08-11 Aidance Skincare And Topical Solutions, Llc Formulations antibiotiques d'application topique
CN102369953B (zh) * 2010-08-18 2014-03-19 赵含淳 一种环保杀菌、消毒、保鲜剂及其制法
CN102175675A (zh) * 2011-01-20 2011-09-07 福州大学 一种检测铜离子的方法
US10272108B2 (en) 2011-05-05 2019-04-30 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
US9327029B2 (en) * 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
DE102012000707A1 (de) * 2012-01-16 2013-07-18 Wilo Se Verwendung einer wässrigen Zusammensetzung aus einem ggf. organisch beschichteten Nanometallpulver wenigstens eines Elements der Gruppe IB der Übergangsmetalle oder einer Legierung dieser Elemente untereinander, ggf. ergänzt durch Wasserstoffperoxid, als Biozid
US8956157B2 (en) * 2012-01-31 2015-02-17 Alexander Philippovich Rutberg Apparatus and method for treatment of periodontal disease
MX2014014128A (es) * 2012-05-21 2015-06-17 Novatec Healthcare Company Ltd Vendaje para heridas que comprende biocelulosa y nanoparticulas de plata.
WO2014052973A1 (fr) * 2012-09-28 2014-04-03 Stelo Technologies Procédés de fabrication de nanoparticules d'argent et leurs applications
GB2511528A (en) 2013-03-06 2014-09-10 Speciality Fibres And Materials Ltd Absorbent materials
WO2014205510A1 (fr) * 2013-06-26 2014-12-31 Silverwater International Pty Ltd Traitement de fluide
US9427411B2 (en) * 2013-08-12 2016-08-30 JoAnna M. Esty Oxygenated antimicrobial topical composition
US10640403B2 (en) 2013-08-15 2020-05-05 Applied Silver, Inc. Antimicrobial batch dilution system
US11618696B2 (en) 2013-08-15 2023-04-04 Applied Silver, Inc. Antimicrobial batch dilution system
US10000881B2 (en) 2013-12-06 2018-06-19 Applied Silver, Inc. Method for antimicrobial fabric application
EP2905034B1 (fr) * 2014-02-06 2024-05-01 Maillefer Instruments Holding S.À.R.L. Solution d'irrigation à nanoparticules pour utilisation dans une méthode de traitement endodontique.
CN103908473B (zh) * 2014-03-28 2016-08-17 长沙迪谷纳米生物科技有限公司 治疗和预防妇女子宫颈癌的纳米银抗癌组合物的应用
CN103933067B (zh) * 2014-05-09 2015-04-15 长沙迪谷纳米生物科技有限公司 一种治疗肺癌的纳米银抗癌组合物及其制备方法和应用
CN104145992B (zh) * 2014-07-24 2018-08-07 温文 一种水体杀藻组合物
WO2016036618A1 (fr) * 2014-09-02 2016-03-10 American Silver, Llc Toxine botulique et particules colloïdales d'argent
TWI549705B (zh) 2014-12-26 2016-09-21 財團法人工業技術研究院 抗菌複合材料及其製造方法
CN104784103B (zh) * 2015-03-31 2017-09-05 青岛科技大学 基于寡聚氨基酸两亲分子可注射抗菌水凝胶
JPWO2016185811A1 (ja) * 2015-05-20 2018-02-22 富士フイルム株式会社 超音波診断用の塗布型接触媒体
US20170050870A1 (en) 2015-08-21 2017-02-23 Applied Silver, Inc. Systems And Processes For Treating Textiles With An Antimicrobial Agent
CN108697094A (zh) * 2016-03-01 2018-10-23 东亚合成株式会社 抗病毒剂、涂料组合物、树脂组合物及抗病毒制品
CA3032422A1 (fr) * 2016-07-29 2018-02-01 Ohio State Innovation Foundation Compositions topiques et ses procedes d'utilisation
CN106266863A (zh) * 2016-08-22 2017-01-04 重庆千贸实业有限公司 妇科凝胶及其制备方法
US10760207B2 (en) 2017-03-01 2020-09-01 Applied Silver, Inc. Systems and processes for treating textiles with an antimicrobial agent
CN108566954A (zh) * 2017-03-10 2018-09-25 洛阳惠中兽药有限公司 一种消毒剂及其制备方法和应用
US11304974B2 (en) 2017-04-10 2022-04-19 Laboratorios Enosan, S.L. Nanosystems comprising silver and antibiotics and their use for the treatment of bacterial infections
EP3619318A4 (fr) 2017-04-30 2020-11-18 Genefluidics, Inc. Génération de données pour utilisation avec des agents antimicrobiens
IT201700098760A1 (it) * 2017-09-04 2019-03-04 Neilos S R L Composizione per patologie respiratorie
EP3727449B1 (fr) * 2017-12-21 2025-03-05 Prebona Ab Composition pharmaceutique comprenant une dispersion colloïdale et un agent thérapeutique et ses procédés et son utilisations
PL237486B1 (pl) * 2018-04-16 2021-04-19 Nano Tech Polska Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa Środek antybakteryjny, zwłaszcza do dezynfekcji skóry rąk
US20200056220A1 (en) * 2018-08-17 2020-02-20 Genefluidics, Inc. Generation of data for use with antimicrobials
US11896612B2 (en) 2019-03-29 2024-02-13 Board Of Trustees Of Michigan State University Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles
CN111067921A (zh) * 2020-01-20 2020-04-28 蓝佳堂生物医药（福建）有限公司 一种口咽用水凝胶的制备方法
CN111657299A (zh) * 2020-07-10 2020-09-15 广州佳乐生态科技有限公司 一种复合纳米离子抑菌剂
CN111821504B (zh) * 2020-08-06 2021-10-29 安信纳米生物科技（珠海）有限公司 一种银离子消毒凝胶及其制备方法
WO2022051264A1 (fr) * 2020-09-04 2022-03-10 Becton, Dickinson And Company Prédiction de concentration inhibitrice minimale dérivée de calcul à partir d'un test de susceptibilité cytométrique à écoulement multidimensionnel
CN114380959A (zh) * 2022-01-25 2022-04-22 江苏经贸职业技术学院 一种具有光催化回收性质的温敏印迹材料的制备方法
CN116496931B (zh) * 2022-12-30 2024-04-05 陕西省微生物研究所 一种阴沟肠杆菌及其制备方法、培养基与应用
WO2024206771A1 (fr) * 2023-03-29 2024-10-03 University Of Florida Research Foundation, Incorporated Nanoparticules d'argent améliorant l'efficacité d'aminoglycosides contre des bactéries résistantes aux antibiotiques

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE630404C (de) * 1934-04-13 1936-05-28 Temmler Werke Desinfektionsmittel
US3303090A (en) * 1963-03-21 1967-02-07 Int Minerals & Chem Corp Composition and method for controlling nematodes with organic metal chelates
US3639575A (en) * 1968-06-19 1972-02-01 Basf Wyandotte Corp Silver ion gel compositions and method of using the same
US4376764A (en) * 1981-08-10 1983-03-15 Basf Wyandotte Corporation Silver ion gel compositions
US4828832A (en) * 1983-09-07 1989-05-09 Laboratorios Biochemie De Mexico Method of manufacturing a composition for treating skin lesions
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
CA2174484A1 (fr) * 1995-04-20 1996-10-21 Masaki Hashimoto Composition sous forme de suspension, agent de preservation pour fleurs coupees
EP0968200A1 (fr) * 1997-02-24 2000-01-05 ZymoGenetics, Inc. Mimetiques de calcitonine
CN1236620A (zh) * 1998-05-26 1999-12-01 李合林 消炎镇痛药液及其配制方法
ES2252962T5 (es) * 1998-08-06 2017-06-21 Jörg Dr.Dr. Schierholz Productos medicinales con actividad farmacológica retardada, y procedimiento para su preparación
US6454754B1 (en) * 1998-10-29 2002-09-24 Steven R. Frank Respiratory infection treatment device
US7135195B2 (en) * 1999-06-01 2006-11-14 American Silver, Llc Treatment of humans with colloidal silver composition
US6214299B1 (en) * 1999-06-01 2001-04-10 Robert J. Holladay Apparatus and method for producing antimicrobial silver solution
EP1066825A1 (fr) * 1999-06-17 2001-01-10 The Procter & Gamble Company Produit antimicrobien pour les soins du corps
CN1114417C (zh) * 1999-09-29 2003-07-16 董志建 治疗真菌病的药剂
US6379712B1 (en) * 2000-09-13 2002-04-30 Globoasia, L.L.C. Nanosilver-containing antibacterial and antifungal granules and methods for preparing and using the same
CN1383812A (zh) * 2002-04-23 2002-12-11 朱红军 防集聚灯芯草纳米银微粉天然药物化妆品及其工业化生产工艺
US7153526B2 (en) * 2003-02-26 2006-12-26 Frank Steven R Treatment of gastrointestinal infections
DE10312617A1 (de) * 2003-03-21 2004-10-07 Henkel Kgaa Keimreduzierendes Wasch- oder Reinigungsmittel und Verfahren zu seiner Herstellung
CA2526150C (fr) * 2003-06-03 2014-05-06 American Biotech Labs Traitement des humains avec une composition d'argent colloidale
EP1781098B1 (fr) * 2004-07-30 2015-10-07 Avent, Inc. Dispositifs antimicrobiens et compositions associees

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12257329B2 (en) * 2022-05-12 2025-03-25 Helix Science LLC Composition for the control of oral malodor compounds

Also Published As

Publication number Publication date
CN101389221A (zh) 2009-03-18
IL184455A0 (en) 2007-10-31
ZA200706496B (en) 2011-06-29
EP1880213A4 (fr) 2010-06-23
WO2006074117A3 (fr) 2008-10-09
CA2624274A1 (fr) 2006-07-13
EP1880213A2 (fr) 2008-01-23
CN101389221B (zh) 2012-06-13
AU2005322839A1 (en) 2006-07-13
US20110262556A1 (en) 2011-10-27
BRPI0519604A2 (pt) 2009-02-25
WO2006074117A2 (fr) 2006-07-13
IL184455A (en) 2015-06-30
AU2005322839B2 (en) 2012-03-29
MX2007008305A (es) 2008-03-11
NZ590025A (en) 2012-06-29
GEP20125593B (en) 2012-08-10
TNSN07257A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
MA29428B1 (fr) Compositions argent/eau, compositions de gels d'argent, compositions a base d'argent, et leurs methodes de production et d'utilisation
Almoudi et al. A systematic review on antibacterial activity of zinc against Streptococcus mutans
Ganguli et al. Nanomaterials in antimicrobial paints and coatings to prevent biodegradation of man-made surfaces: A review
WO2007056424A3 (fr) Compositions d'emulsion a liberation controlee
AR040110A1 (es) Formulaciones de fibrato en nanoparticulas
TW200637580A (en) Modified powder and a cosmetic using the same
AU6701101A (en) Compositions and methods to improve the oral absorption of antimicrobial agents
ATE311750T1 (de) Antibakterielle mittel sowie diese enthaltende antibakterielle und deodorierende lösung
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
FR2636811A1 (fr) Poudres d'hydroxyapatite antiseptiques et leurs procedes de preparation
WO2008016664A3 (fr) Compositions et procédés pour le traitement du cancer par des nanoémulsions de dacarbazine
YU78903A (sh) Upotreba etoksilata masnih alkohola kao promotora penetracije
Hoseinzadeh et al. Antimicrobial efficacy of zinc oxide nanoparticles suspension against Gram negative and Gram positive bacteria
Li et al. Promotion of reactive oxygen species activated by nanosilver surface engineering for resistant bacteria-infected skin tissue therapy: P.-P. Li et al.
Khatoon et al. Nano-sized copper particles: Chemical synthesis, characterization, and their size and surface charge dependent antibacterial potential
CA2521909A1 (fr) Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
EP1876604A4 (fr) Composition d' encre et materiau metallique
MX2010007498A (es) Composiciones fotoprotectoras contra radiacion ultravioleta visiblemente transparentes.
Azócar et al. A systematic study of antibacterial silver nanoparticles: efficiency, enhanced permeability, and cytotoxic effects
ATE419834T1 (de) Nanopartikel bestehend aus einem arzneistoff und copolymeren von vinyl pyrrolidon und vinyl acetat als oberflächenstabilisatoren
EA200501752A1 (ru) Композиции и способы чернения и придания коррозионно-стойких свойств цинку или другим активным металлам
TW200624571A (en) Oxide-dispersion strengthened platinum material
JP2009155262A (ja) 抗ウイルス剤
KR100425983B1 (ko) 안정화된 은 콜로이드 조성물, 안정화된 은 콜로이드조성물의 제조 방법 및 이를 함유하는 화장료 조성물
HUP0203345A2 (hu) Ivóvízjavító szer